C1QL2
Complement C1q-like protein 2
Also known as: C1QL2_HUMAN, C1QTNF10, CTRP10
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q7Z5L3
- Gene
- C1QL2
- Ensembl
- ENSG00000144119
- Chromosome
- 2
- Canonical length
- 287 aa
- Protein class
- Predicted secreted proteins, Transporters
- Subcellular location
- Vesicles,Cytosol
- Secretome location
- Secreted in brain
- Quaternary structure
- Homotrimer
OverviewNCBI Gene
Predicted to enable identical protein binding activity. Predicted to be involved in neurotransmitter receptor localization to postsynaptic specialization membrane; postsynaptic density assembly; and regulation of synapse maturation. Predicted to be located in extracellular region. Predicted to be part of collagen trimer. Predicted to be active in cerebellar climbing fiber to Purkinje cell synapse; hippocampal mossy fiber to CA3 synapse; and synaptic cleft. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
287 residues, UniProt reviewed canonical sequence.
>Q7Z5L3|C1QL2
1 MALGLLIAVP LLLQAAPRGA AHYEMMGTCR MICDPYTAAP GGEPPGAKAQ PPGPSTAALE
61 VMQDLSANPP PPFIQGPKGD PGRPGKPGPR GPPGEPGPPG PRGPPGEKGD SGRPGLPGLQ
121 LTAGTASGVG VVGGGAGVGG DSEGEVTSAL SATFSGPKIA FYVGLKSPHE GYEVLKFDDV
181 VTNLGNHYDP TTGKFSCQVR GIYFFTYHIL MRGGDGTSMW ADLCKNGQVR ASAIAQDADQ
241 NYDYASNSVV LHLDSGDEVY VKLDGGKAHG GNNNKYSTFS GFLLYPDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against C1QL2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.5
- Highest tissue expression
- 26 nTPM
Expression across tissuesHPA
Tissue
- hippocampal formation: 26 nTPM
- amygdala: 24 nTPM
- cerebral cortex: 18 nTPM
- hypothalamus: 12 nTPM
- basal ganglia: 11 nTPM
- midbrain: 7.6 nTPM
Single-cell type
- retinal amacrine cells: 151 nCPM
- oligodendrocyte progenitor cells: 52 nCPM
- astrocytes: 6.6 nCPM
- brain excitatory neurons: 4.7 nCPM
- other brain neurons: 4.6 nCPM
- breast secretory cells: 3.2 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- hippocampal formation: 49 nTPM
- hypothalamus: 36 nTPM
- amygdala: 31 nTPM
- cerebral cortex: 29 nTPM
- thalamus: 20 nTPM
- basal ganglia: 14 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.22
- gnomAD pLI
- 0.04
- gnomAD missense Z
- 1.65
- DepMap mean gene effect
- -0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- neurotransmitter receptor localization to postsynaptic specialization membrane
- postsynaptic density assembly
- regulation of synapse maturation
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of C1QL2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads C1QL2 as an antibody target. Whether an autoantibody or antibody against C1QL2 could matter depends on whether native C1QL2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
C1QL2 is annotated as secreted, so native C1QL2 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label C1QL2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...